Healthcare
Based on ARK ETF real-time + 13F quarterly filings
13F data may be delayed up to 90 days.
※ Analyst opinions are for reference only and do not constitute investment advice. Each securities firm may have different opinions.
Natera, Inc. is a diagnostics company that provides molecular testing services globally. Their main products include genetic tests for prenatal screening (Panorama, Vistara), carrier screening (Horizon), cancer screening (Empower, Signatera), and transplant monitoring (Prospera). Natera serves various healthcare providers and research entities, positioning itself as a leader in advanced genetic diagnostics.
AI-generated summary. Not investment advice.